Annals of the New York Academy of Sciences · 1987 · 13 citations · 14 references
MedicineNeurobiologyPharmacologyCellular PharmacologyNeurochemistryNeuropharmacologyDopaminergic PharmacologyLigand BindingMonoamine NeurochemistryReceptor BindingReceptor PharmacologyReceptor PhysiologyDopamine Receptor SubtypesNeurotransmitter Binding SitesSelective Binding Sites
Using [3H]DA as the ligand of choice, we have shown that rat thymocytes possess dopamine binding sites. The binding of [3H]DA was specific, saturable and of high affinity. [3H]DA binding was rapid and reversible; [3H]DA was totally displaced by low concentrations of dopamine, norepinephrine, and apomorphine. The binding sites were insensitive to neuroleptic drugs such as sulpiride, bromocriptine, and haloperidol. On the basis of these findings, we have suggested that thymocytes possess a D-3 receptor type.
14
Noradrenergic and peptidergic innervation of lymphoid tissue
Felten Dl, SY Felten, SL Carlson et al. · The Journal of Immunology · 1985 · 1K citations
Medicine, Anatomy, Neurobiology +17
Enhancement of natural cytotoxicity by beta-endorphin.
Paul M. Mathews, Christopher J. Froelich, Wilmer L. Sibbitt et al. · The Journal of Immunology · 1983 · 462 citations · Full text
Specific Nonopiate Receptors for β-Endorphin
Eli Hazum, Kwen‐Jen Chang, Pedro Cuatrecasas · Science · 1979 · 412 citations